Weaver C. Barksdale & Associates’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
Other funds holding EMN
VPM
VCM
Weaver C. Barksdale & Associates's EMN Position: Q1 2026 in Review
Weaver C. Barksdale & Associates increased its Eastman Chemical (EMN) stake by 5.9% in Q1 2026, buying an estimated $47.5K and bringing the position to 11,897 shares worth $908K. The position accounts for 0.87% of the portfolio, ranked #59.
Weaver C. Barksdale & Associates first reported a position in EMN in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.02M in Q4 2021. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.
- Weaver C. Barksdale & Associates held 11,897 shares of Eastman Chemical worth $908K as of Q1 2026.
- Weaver C. Barksdale & Associates bought 659 Eastman Chemical shares in Q1 2026, an estimated $47.5K.
- Eastman Chemical made up 0.87% of Weaver C. Barksdale & Associates's portfolio in Q1 2026, its #59 holding.
- Weaver C. Barksdale & Associates first reported a position in Eastman Chemical in Q4 2021 and has held it in 18 quarters since.
- Weaver C. Barksdale & Associates's Eastman Chemical position peaked at $2.02M in Q4 2021.
- 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.
Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2026, filed 14 May 2026.